Share Twitter LinkedIn Facebook Email Tian Zhang, MD Duke University Medical Center, explains the Challenges of VEGF & Immunotherapy Combinations Resistance patterns in patients disease progression at Kidney Cancer Association 2017 in Miami.
ASH 2025 MDS/ALL Highlights: Verona Trial Lessons & CLEVER Pathway | Dr. Jeyakumar Acute Lymphoblastic Leukemia 5 Mins Read
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read